Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00714038
Other study ID # NIS-RDK-DUM-2008/1
Secondary ID
Status Completed
Phase N/A
First received July 10, 2008
Last updated March 8, 2011
Start date May 2008
Est. completion date December 2010

Study information

Verified date March 2011
Source AstraZeneca
Contact n/a
Is FDA regulated No
Health authority Denmark: Danish Dataprotection Agency
Study type Observational

Clinical Trial Summary

Quality Improvement in Primary Care: delegation of check-ups to nurses in general practice


Recruitment information / eligibility

Status Completed
Enrollment 2122
Est. completion date December 2010
Est. primary completion date December 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- diagnosed with asthma

Exclusion Criteria:

- patients with copd

Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Denmark Research Site Aabenraa
Denmark Research Site Aalborg
Denmark Research Site Abybro
Denmark Research Site Albertslund
Denmark Research Site Alborg
Denmark Research Site Arhus
Denmark Research Site Arhus C
Denmark Research Site Arhus N
Denmark Research Site Ballerup
Denmark Research Site Birkerod
Denmark Research Site Brabrand
Denmark Research Site Bronshoj
Denmark Research Site Bryrup
Denmark Research Site Christiansfeld
Denmark Research Site Dybvad
Denmark Research Site Erslev
Denmark Research Site Espergorde
Denmark Research Site Fakse
Denmark Research Site Fredericia
Denmark Research Site Frederikshavn
Denmark Research Site Frostruo
Denmark Research Site Gedsted
Denmark Research Site Gram
Denmark Research Site Haderslev
Denmark Research Site Hadsund
Denmark Research Site Hasselager
Denmark Research Site Hedehusene
Denmark Research Site Helsingor
Denmark Research Site Herfolge
Denmark Research Site Herlev
Denmark Research Site Herning
Denmark Research Site Hinnerup
Denmark Research Site Hjorring
Denmark Research Site Hobro
Denmark Research Site Hojer
Denmark Research Site Holbaek
Denmark Research Site Holstebro
Denmark Research Site Holte
Denmark Research Site Horning
Denmark Research Site Horsens
Denmark Research Site Horsholm
Denmark Research Site Humlaek
Denmark Research Site Hurup Thy
Denmark Research Site Ikast
Denmark Research Site Jaegerspris
Denmark Research Site Karlslunde
Denmark Research Site Karup J.
Denmark Research Site Kastrup
Denmark Research Site Kbh. NV
Denmark Research Site Kerteminde
Denmark Research Site Kjellerup
Denmark Research Site Kobenhavn S
Denmark Research Site Koge
Denmark Research Site Kolding
Denmark Research Site Kongens Lyngby
Denmark Research Site Lasby
Denmark Research Site Lemvig
Denmark Research Site Middelfart
Denmark Research Site Moldrup
Denmark Research Site Naestved
Denmark Research Site Nordborg
Denmark Research Site Nyborg
Denmark Research Site Nykobing F
Denmark Research Site Nykobing Sj?lland
Denmark Research Site Odense C
Denmark Research Site Randers
Denmark Research Site Ribe
Denmark Research Site Rodovre
Denmark Research Site Roskilde
Denmark Research Site Sakskobing
Denmark Research Site Silkeborg
Denmark Research Site Skive
Denmark Research Site Skorping
Denmark Research Site Skovlunde
Denmark Research Site Slagelse
Denmark Research Site Slangerup
Denmark Research Site Snekkersten
Denmark Research Site Solbjerg
Denmark Research Site Solrod Srand
Denmark Research Site Sonderborg
Denmark Research Site Storvorde
Denmark Research Site Stovring
Denmark Research Site Svendborg
Denmark Research Site Tarm
Denmark Research Site Terndrup
Denmark Research Site Thisted
Denmark Research Site Uldum
Denmark Research Site Vallensaek Strand
Denmark Research Site Vanlose
Denmark Research Site Varde
Denmark Research Site Vejle
Denmark Research Site Viborg
Denmark Research Site Virum
Denmark Research Site Vojens

Sponsors (1)

Lead Sponsor Collaborator
AstraZeneca

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Lung function, improvements in lung function over time, patient compliance with treatment baseline, when necessary and at 1 year control No
Secondary Number of visits per patient, drop-out rate annually No
See also
  Status Clinical Trial Phase
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device